On the correspondence between the transcriptomic response of a compound and its effects on its targets
Engler Hart, C.; Ence, D.; Healey, D.; Domingo-Fernandez, D.
Show abstract
Better understanding the transcriptomic response produced by a compound perturbing its targets can shed light on the underlying biological processes regulated by the compound. However, establishing the relationship between the induced transcriptomic response and the target of a compound is non-trivial, partly because targets are rarely differentially expressed. Thus, connecting both modalities requires orthogonal information (e.g., pathway or functional information). Here, we present a comprehensive study aimed at exploring this relationship by leveraging thousands of transcriptomic experiments and target data for over 2,000 compounds. Firstly, we confirmed that compound-target information does not correlate as expected with the transcriptomic signatures induced by a compound. However, we demonstrate how the concordance between both modalities can be increased by connecting pathway and target information. Additionally, we investigated whether compounds that target the same proteins induce a similar transcriptomic response and conversely, whether compounds with similar transcriptomic responses share the same target proteins. While our findings suggest that this is generally not the case, we did observe that compounds with similar transcriptomic profiles are more likely to share at least one protein target, as well as common therapeutic applications. Lastly, we present a case scenario on a few compound pairs with high similarity to demonstrate how the relationship between both modalities can be exploited for mechanism of action deconvolution.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Design and application of a knowledge network for automatic prioritization of drug mechanisms 95%
- Interpretable deep learning architectures for improving drug response prediction performance: myth or reality? 94%
- Strategies for robust, accurate, and generalizable benchmarking of drug discovery platforms 93%
Similar papers in this journal
Similar papers in this journal
- Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery 95%
- Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with Deep Graph Networks 94%
- Protein Domain-Based Prediction of Compound-Target Interactions and Experimental Validation on LIM Kinases 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.